Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
CHOLINE
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
CHOLINE
Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to...